Big Pharma in Canada is far behind the curve when it comes to disclosing what payments to health-care professionals are for.
Politicians should be subject to a penalty regime similar to the far more stringent one that applies to company directors.
The Trump administration may reverse a recent push to require oil companies to disclose more information about climate change risks to investors. Is that a good thing?
The SEC and others are pressing Exxon to disclose more climate change risks to investors. But new research suggests shareholders are already pricing in those costs on their own.
We asked a group of scholars to listen to Clinton vs. Trump and pick just one quote to react to. Here’s what the experts heard.